PASELLO, GIULIA

PASELLO, GIULIA  

Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG  

Mostra records
Risultati 1 - 20 di 187 (tempo di esecuzione: 0.043 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Dissecting the prognostic role of metabolic markers in lung neuroendocrine Tumors: The MONET study 2026 Pasello, GiuliaPigato, GiuliaPezzuto, FedericaScattolin, DanielaMaso, Alessandro DalBonanno, LauraCalabrese, FiorellaDell'Amore, AndreaGuarneri, ValentinaIndraccolo, Stefano + LUNG CANCER - -
Reframing tumor bed evaluation in non-small cell lung cancer: histopathological challenges and future directions in the era of neoadjuvant immunotherapy 2026 Pezzuto, FedericaFaccioli, EleonoraMaggioni, GiuseppeGiraudo, ChiaraBonanno, LauraPasello, GiuliaDell'Amore, AndreaCalabrese, Fiorella + FRONTIERS IN ONCOLOGY - -
Treatment response after induction therapy in advanced thymic tumors: results from the Italian nationwide TYME database 2026 Fabbri, AlessandraFranceschini, DavidePasello, Giulia + LUNG CANCER - -
Adjuvant atezolizumab in surgically resected NSCLC patients with PD-L1 expression ≥50%: real-world data from the italian ATLAS registry 2025 Pasello, GiuliaPavan, Alberto + THE ONCOLOGIST - -
Advanced-stage ALK-positive non-small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database 2025 Scattolin, DanielaPavan, AlbertoPasello, Giulia + LUNG CANCER - -
An open-label, randomized phase III study of early switch maintenance vs delayed second-line nivolumab in advanced stage squamous non-small cell lung cancer (NSCLC) patients after standard first-line platinum-based chemotherapy-EDEN trial GOIRC 04–2016 2025 Pasello, Giulia + LUNG CANCER - -
Baseline levels and dynamic changes of cfDNA, tumor fraction and mutations to anticipate the clinical course of small cell lung cancer (SCLC) patients treated with first-line atezolizumab and chemotherapy: an hypothesis generating study (CATS/ML43257) 2025 Pasello, GiuliaPigato, GiuliaScattolin, DanielaLando, StefaniaPotente, SaraRomualdi, ChiaraMaso, Alessandro DalBonanno, LauraGuarneri, ValentinaIndraccolo, Stefano + JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH - -
Braf-mutant metastatic non-small-cell lung cancer: Real world data from the Italian biomarker atlas database 2025 Pavan, AlbertoPasello, Giulia + EUROPEAN JOURNAL OF CANCER - -
Carboplatin, etoposide, atezolizumab, and bevacizumab in the first-line treatment of patients with extensive stage small-cell lung cancer: the GOIRC-01-2019 CeLEBrATE study 2025 Pasello, Giulia + JOURNAL FOR IMMUNOTHERAPY OF CANCER - -
Circulating microRNAs as biomarkers for risk assessment and prognostic stratification of pleural mesothelioma 2025 Scattolin, DanielaD'Agostino, Donna MPasello, GiuliaCiminale, Vincenzo + LUNG CANCER - -
Clinical insight on the pathway of SLFN11 as emergent biomarker in SCLC 2025 Scattolin, DanielaGuarneri, ValentinaPasello, Giulia + CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY - -
COMPEL: osimertinib plus platinum-based chemotherapy in patients with EGFR-mutated advanced NSCLC and progression on first-line osimertinib 2025 Pasello, GWang, Q + ESMO OPEN - -
Healthcare Costs by Comorbidity Patterns in Lung Cancer Patients 2025 Buja, AlessandraRea, FedericoRigon, LeonardoArcara, GiorgioPasello, GiuliaGuarneri, Valentina + CANCERS - -
Liver kinase B1 expression is associated with improved prognosis and tumor immune microenvironment features in small cell lung cancer 2025 Dal Maso, AlessandroMinuzzo, Sonia AnnaPezzuto, FedericaZulato, ElisabettaPasello, GiuliaCalabrese, FiorellaFassan, MatteoRea, FedericoGuarneri, ValentinaIndraccolo, StefanoBonanno, Laura + FRONTIERS IN ONCOLOGY - -
Machine Learning Identifies a Distinct Microbiota Signature in Immune Checkpoint Inhibitor Colitis Compared with Inflammatory Bowel Disease 2025 Patuzzi, IlariaBertin, LuisaBonazzi, EricaDe Barba, CaterinaDal Maso, AlessandroZingone, FabianaBurra, PatriziaDei Tos, Angelo PaoloPasello, GiuliaBonanno, LauraSavarino, Edoardo Vincenzo + THE ONCOLOGIST - -
Multimodality treatment in synchronous oligometastatic NSCLC: Analysis of the ETOP CHESS trial 2025 Pasello, Giulia + LUNG CANCER - -
NON-SMALL-CELL LUNG CANCER: Real-World Population-Based Cohorts' Study 2025 Buja, AlessandraRea, FedericoZanovello, AnnaPasello, GiuliaGuarneri, Valentina + CANCERS - -
Outcome and safety of lurbinectedin as compassionate use in extensive stage small cell lung cancer: A multicentric international cohort 2025 Scattolin, DanielaMaso, Alessandro DalGuarneri, ValentinaPasello, Giulia + EUROPEAN JOURNAL OF CANCER - -
Pathologic assessment of resected stage III non-small cell lung cancer after neoadjuvant chemotherapy: identification of additional prognostic factors 2025 Vedovelli, LucaPezzuto, FedericaSchiavon, MarcoRea, FedericoPasello, GiuliaCalabrese, Fiorella + HISTOPATHOLOGY - -
Patterns of Comorbidities in Lung Cancer Patients and Survival 2025 Buja, AlessandraRea, FedericoRigon, LeonardoArcara, GiorgioPasello, GiuliaGuarneri, Valentina + CANCERS - -